Frederick Naftolin

Author PubWeight™ 48.26‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Arterial imaging outcomes and cardiovascular risk factors in recently menopausal women: a randomized trial. Ann Intern Med 2014 2.48
2 Women, hormones, and clinical trials: a beginning, not an end. J Appl Physiol (1985) 2005 1.60
3 Estrogen receptor alpha interacts with Galpha13 to drive actin remodeling and endothelial cell migration via the RhoA/Rho kinase/moesin pathway. Mol Endocrinol 2006 1.35
4 Postmenopausal hormone therapy: new questions and the case for new clinical trials. Menopause 2006 1.18
5 Is the estrogen controversy over? Deconstructing the Women's Health Initiative study: a critical evaluation of the evidence. Ann N Y Acad Sci 2005 1.04
6 Ezrin, a membrane-cytoskeletal linking protein, is highly expressed in atypical endometrial hyperplasia and uterine endometrioid adenocarcinoma. Cancer Lett 2002 1.03
7 Timing and duration of menopausal hormone treatment may affect cardiovascular outcomes. Am J Med 2011 1.02
8 Circulating monocytic cells infiltrate layers of anterograde axonal degeneration where they transform into microglia. FASEB J 2005 1.01
9 Estradiol-induced ezrin overexpression in ovarian cancer: a new signaling domain for estrogen. Cancer Lett 2005 1.01
10 Better oral reading and short-term memory in midlife, postmenopausal women taking estrogen. Menopause 2003 1.01
11 Intra-thoracic fat, cardiometabolic risk factors, and subclinical cardiovascular disease in healthy, recently menopausal women screened for the Kronos Early Estrogen Prevention Study (KEEPS). Atherosclerosis 2011 0.99
12 Estradiol prevents neural tau hyperphosphorylation characteristic of Alzheimer's disease. Ann N Y Acad Sci 2005 0.99
13 Is the WHI relevant to HRT started in the perimenopause? Endocrine 2004 0.97
14 Genetic polymorphisms associated with carotid artery intima-media thickness and coronary artery calcification in women of the Kronos Early Estrogen Prevention Study. Physiol Genomics 2012 0.93
15 Advantages of the dental practice-based research network initiative and its role in dental education. J Dent Educ 2011 0.91
16 Person-centric clinical trials: an opportunity for the good clinical practice (GCP)-practice-based research network. J Clin Pharmacol 2013 0.90
17 The pros and cons of plant estrogens for menopause. J Steroid Biochem Mol Biol 2012 0.87
18 Associations between retinol-binding protein 4 and cardiometabolic risk factors and subclinical atherosclerosis in recently postmenopausal women: cross-sectional analyses from the KEEPS study. Cardiovasc Diabetol 2012 0.86
19 Estradiol and tryptophan depletion interact to modulate cognition in menopausal women. Neuropsychopharmacology 2006 0.86
20 Modern pathology: protein mis-folding and mis-processing in complex disease. Curr Protein Pept Sci 2007 0.85
21 Estrogens regulate posttranslational modification of neural cell adhesion molecule during the estrogen-induced gonadotropin surge. Endocrinology 2009 0.84
22 Estradiol regulates expression of polysialated neural cell adhesion molecule by human vascular endothelial cells. Reprod Sci 2010 0.83
23 The Timing Hypothesis remains a valid explanation of differential cardioprotective effects of menopausal hormone treatment. Menopause 2011 0.83
24 Hormonal regulation of apoptosis and the Fas and Fas ligand system in human endometrial cells. Mol Hum Reprod 2002 0.82
25 Controlled fine needle biopsy of the uterine cervix during pregnancy. Reprod Sci 2011 0.82
26 Neuroendocrine control of ovulation. Gynecol Endocrinol 2012 0.82
27 Is progestogen supplementation of ERT really necessary? Menopause 2002 0.81
28 Brain health and cognitive and mood disorders in ageing women. Best Pract Res Clin Obstet Gynaecol 2013 0.80
29 Characterization of vascular disease risk in postmenopausal women and its association with cognitive performance. PLoS One 2013 0.80
30 The resistance to depressive relapse in menopausal women undergoing tryptophan depletion: preliminary findings. J Psychopharmacol 2006 0.80
31 Angiotensin II induces apoptosis in human mural granulosa-lutein cells, but not in cumulus cells. Fertil Steril 2008 0.80
32 Minimally invasive method for murine brain fixation. Biotechniques 2005 0.80
33 Ectopic fat and adipokines in metabolically benign overweight/obese women: the Kronos Early Estrogen Prevention Study. Obesity (Silver Spring) 2013 0.79
34 Dehydroepiandrosterone (DHEA) inhibition of monocyte binding by vascular endothelium is associated with sialylation of neural cell adhesion molecule. Reprod Sci 2012 0.79
35 Low-dose estrogen therapy for prevention of osteoporosis: working our way back to monotherapy. Menopause 2006 0.79
36 Estradiol-induced synaptic remodeling of tyrosine hydroxylase immunopositive neurons in the rat arcuate nucleus. Endocrinology 2008 0.78
37 Development of low-dose reproductive hormone therapies in China. Gynecol Endocrinol 2006 0.78
38 Can menopausal hormone therapy prevent coronary heart disease? Trends Endocrinol Metab 2008 0.78
39 The evolutionary origin and significance of menopause. Menopause 2011 0.78
40 Menopause: developing a rational treatment plan. Gynecol Endocrinol 2007 0.77
41 Expression and activation of the membrane-cytoskeleton protein ezrin during the normal endometrial cycle. Fertil Steril 2012 0.77
42 Depot-medroxyprogesterone acetate: an update. Arch Gynecol Obstet 2008 0.77
43 Phytoestrogens: are they really estrogen mimics? Fertil Steril 2002 0.76
44 Localized accumulation of angiotensin II and production of angiotensin-(1-7) in rat luteal cells and effects on steroidogenesis. Am J Physiol Endocrinol Metab 2006 0.76
45 What can we learn from design faults in the Women's Health Initiative randomized clinical trial? Bull NYU Hosp Jt Dis 2009 0.76
46 Protein flexibility and conformational states of Leishmania antigen eIF-4A: identification of a novel plausible protein adjuvant using comparative genomics and molecular modeling. J Biomol Struct Dyn 2012 0.76
47 Practice based research networks impacting periodontal care: PEARL Initiative. J Periodontol 2012 0.75
48 Abnormal fingernail beds following carbon monoxide poisoning: a case report and review of the literature. J Med Case Rep 2014 0.75
49 Longitudinal changes in menopausal symptoms comparing women randomized to low-dose oral conjugated estrogens or transdermal estradiol plus micronized progesterone versus placebo: the Kronos Early Estrogen Prevention Study. Menopause 2016 0.75
50 Preventing Alzheimer disease and cognitive decline. Ann Intern Med 2011 0.75
51 Expression of angiotensin II type 1 (AT1) and angiotensin II type 2 (AT2) receptors in human granulosa-lutein (GL) cells: correlation with infertility diagnoses. Fertil Steril 2009 0.75
52 Sex steroids and the brain. Gynecol Endocrinol 2008 0.75
53 Menopausal hormone therapy and risk for cardiovascular disease in the WHI trial. Ann Intern Med 2010 0.75
54 Csapo redux, but more veils remain. J Soc Gynecol Investig 2002 0.75
55 Stopping HABITS. Lancet 2004 0.75
56 Progesterone abolishes estrogen and/or atorvastatin endothelial dependent vasodilatory effects. Atherosclerosis 2005 0.75
57 The International Society of Gynecological Endocrinology and its president. Gynecol Endocrinol 2012 0.75
58 The separation of sexual activity and reproduction in human social evolution. Adv Exp Med Biol 2014 0.75
59 The selective estrogen receptor modulator DT56a (Femarelle) does not affect platelet reactivity in normal or thrombophilic postmenopausal women. Menopause 2011 0.75
60 Direct identification of proteins from T47D cells and murine brain tissue by matrix-assisted laser desorption/ionization post-source decay/collision-induced dissociation. Rapid Commun Mass Spectrom 2007 0.75
61 Toward optimal health: managing women's medical challenges in midlife. J Womens Health (Larchmt) 2008 0.75
62 How we almost discovered LH receptors, but didn't. Gynecol Endocrinol 2012 0.75
63 ISGE statement on oral emergency contraception. Gynecol Endocrinol 2014 0.75
64 Unveiling the unfolding pathway of F5F8D disorder-associated D81H/V100D mutant of MCFD2 via multiple molecular dynamics simulations. J Biomol Struct Dyn 2012 0.75
65 Ezrin overexpression by transformed human ovarian surface epithelial cells, ovarian cleft cells, and serous ovarian adenocarcinoma cells. Reprod Sci 2012 0.75
66 Post hoc magnetic resonance imaging cannot justify the conclusions of WHIMS. Gynecol Endocrinol 2010 0.75